Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EIF4A1 | P60842 | 18/20 | 0.81 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.81 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.81 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.69 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.66 |
| ▸ | RELA | Q04206 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29531825 | 1.00 | EIF4A1 (0.81) | EIF4A1CYP3A4HIF1APAX8NFKB1 | |
| SCHEMBL23226909 | 1.00 | EIF4A1 (0.81) | EIF4A1CYP3A4HIF1APAX8NFKB1 | |
| SCHEMBL20496140 | 1.00 | EIF4A1 (0.81) | EIF4A1CYP3A4HIF1APAX8NFKB1 | |
| SCHEMBL29531653 | 0.94 | EIF4A1 (0.81) | EIF4A1CYP3A4HIF1APAX8 | |
| SCHEMBL17414018 | 0.94 | EIF4A1 (0.81) | EIF4A1CYP3A4HIF1APAX8 | |
| SCHEMBL23463325 | 0.94 | EIF4A1 (0.81) | EIF4A1CYP3A4HIF1APAX8NFKB1 | |
| SCHEMBL18836582 | 0.94 | EIF4A1 (0.81) | EIF4A1CYP3A4HIF1APAX8 | |
| SCHEMBL18835977 | 0.94 | EIF4A1 (0.70) | EIF4A1CYP3A4HIF1APAX8NFKB1 | |
| SCHEMBL20496143 | 0.93 | EIF4A1 (0.80) | EIF4A1CYP3A4HIF1APAX8NFKB1 | |
| SCHEMBL18836072 | 0.93 | EIF4A1 (0.80) | EIF4A1CYP3A4HIF1APAX8NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3418273-A1 | FLAVAGLINE DERIVATIVES | PIERRE FABRE MEDICAMENT (FR) | 2018-12-26 | — | — | EP | disclosed |
| EP-3164393-B1 | FLAVAGLINE DERIVATIVES | PF MEDICAMENT (FR) | 2018-09-19 | — | — | EP | disclosed |